Julie dela Cruz-Mulders

Julie Dela Cruz-Mulders, PhD, PhD, currently serves as Director, Neurology Rare Disease at argenx, where responsibilities include overseeing medical science liaison functions. Previous experience includes roles at Eli Lilly and Company and Allergan, focusing on medical science liaison activities and global medical communications in dermatology and aesthetics. Julie's academic background encompasses two PhDs—one in Neuroscience from Maastricht University and another in Psychology with a specialization in neuropsychology from The Graduate Center, City University of New York. Additional professional experiences include postdoctoral research at UC Irvine, clinical research assistance at Clinilabs, and academic instruction in psychology courses. Julie has a strong research portfolio linked to neurotransmitter effects on learning and behavioral patterns and has collaborated on numerous product launches and publications throughout a diverse career.